Nifty
:
22620.40
Sensex
:
73730.16
50.05 (0.22%)
-609.28 (-0.82%)
Nifty
Sensex
:
:
22620.40
73730.16
50.05 (0.22%)
-609.28 (-0.82%)

Jupiter Bioscience Ltd.

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 524826 | NSE: JUPITER

NSE BSE
Not traded in the last 30 days
  • Open
  • High
  • Low
  • Previous Close
  •  N/A
  •  N/A
  •  N/A
  •  N/A
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  N/A
  •  N/A
  •  N/A
  •  N/A

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 24.79
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 475.02
  • 25.19%
  • N/A

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 4.62%
  • 15.65%
  • 76.33%
  • FII
  • DII
  • Others
  • 0.01%
  • 0.37%
  • 3.02%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Mar 06
Mar 05
Net Sales
-
331.26
232.55
177.52
154.41
121.30
91.46
80.31
Net Sales Growth
-
42.45%
31.00%
14.97%
27.30%
32.63%
13.88%
 
Cost Of Goods Sold
-
128.93
72.20
50.30
50.36
44.77
48.18
49.74
Gross Profit
-
202.33
160.35
127.21
104.05
76.53
43.29
30.57
GP Margin
-
61.08%
68.95%
71.66%
67.39%
63.09%
47.33%
38.06%
Total Expenditure
-
185.04
113.11
89.63
86.09
69.88
49.08
44.23
Power & Fuel Cost
-
2.65
2.55
2.38
2.07
1.01
1.00
0.90
% Of Sales
-
0.80%
1.10%
1.34%
1.34%
0.83%
1.09%
1.12%
Employee Cost
-
10.16
7.61
7.25
6.05
4.40
3.80
3.08
% Of Sales
-
3.07%
3.27%
4.08%
3.92%
3.63%
4.15%
3.84%
Manufacturing Exp.
-
26.13
19.01
18.39
16.40
10.67
2.39
2.56
% Of Sales
-
7.89%
8.17%
10.36%
10.62%
8.80%
2.61%
3.19%
General & Admin Exp.
-
9.17
7.32
6.88
5.58
3.96
3.61
2.92
% Of Sales
-
2.77%
3.15%
3.88%
3.61%
3.26%
3.95%
3.64%
Selling & Distn. Exp.
-
1.41
0.81
0.81
2.01
1.43
1.41
1.02
% Of Sales
-
0.43%
0.35%
0.46%
1.30%
1.18%
1.54%
1.27%
Miscellaneous Exp.
-
6.58
3.62
3.62
3.62
3.64
2.93
1.92
% Of Sales
-
1.99%
1.56%
2.04%
2.34%
3.00%
3.20%
2.39%
EBITDA
-
146.22
119.44
87.89
68.32
51.42
42.38
36.08
EBITDA Margin
-
44.14%
51.36%
49.51%
44.25%
42.39%
46.34%
44.93%
Other Income
-
0.17
0.14
2.35
1.26
0.14
0.26
0.27
Interest
-
29.35
26.13
19.36
12.71
8.15
7.31
5.72
Depreciation
-
58.76
44.38
33.11
22.41
16.35
11.98
9.80
PBT
-
58.28
49.07
37.75
34.46
27.06
23.35
20.83
Tax
-
6.92
6.59
4.71
4.76
6.80
4.97
5.91
Tax Rate
-
11.87%
13.43%
12.48%
13.81%
25.13%
21.28%
28.37%
PAT
-
51.36
42.48
33.04
29.70
20.26
18.38
14.92
PAT before Minority Interest
-
51.36
42.48
33.04
29.70
20.26
18.38
14.92
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
15.50%
18.27%
18.61%
19.23%
16.70%
20.10%
18.58%
PAT Growth
-
20.90%
28.57%
11.25%
46.59%
10.23%
23.19%
 
EPS
-
8.23
6.81
5.29
4.76
3.25
2.95
2.39

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Mar 06
Mar 05
Shareholder's Funds
853.59
408.25
335.11
308.70
170.71
120.39
100.39
Share Capital
64.53
18.23
16.13
18.13
9.86
8.86
8.86
Total Reserves
744.10
345.06
289.78
281.22
138.71
107.38
91.53
Non-Current Liabilities
475.30
445.35
314.19
206.73
179.68
115.54
85.41
Secured Loans
405.65
392.05
276.28
170.92
128.14
86.76
73.81
Unsecured Loans
48.88
35.42
24.58
29.25
51.40
27.65
9.92
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
34.89
19.26
20.84
23.18
20.62
16.37
11.06
Trade Payables
10.07
9.79
7.01
4.74
4.31
4.47
4.29
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
0.11
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
24.82
9.46
13.83
18.44
16.31
11.90
6.66
Total Liabilities
1,363.78
872.86
670.14
538.61
371.01
252.30
196.86
Net Block
513.07
407.52
316.92
240.90
143.48
95.56
89.42
Gross Block
730.27
565.96
430.98
321.80
201.97
137.70
119.57
Accumulated Depreciation
217.20
158.44
114.06
80.90
58.49
42.14
30.16
Non Current Assets
1,072.98
641.66
472.22
365.01
225.17
138.19
108.99
Capital Work in Progress
259.38
216.60
145.69
123.11
80.69
41.63
17.58
Non Current Investment
300.52
17.54
9.61
1.00
1.00
1.00
2.00
Long Term Loans & Adv.
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
208.52
168.86
138.44
115.71
86.40
52.39
38.94
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
77.91
68.41
57.64
48.85
38.70
25.04
22.92
Sundry Debtors
82.05
58.35
49.72
39.59
29.06
20.36
13.12
Cash & Bank
4.29
6.44
1.57
2.39
2.48
1.42
0.97
Other Current Assets
44.27
0.00
0.00
0.00
16.16
5.57
1.94
Short Term Loans & Adv.
44.27
35.65
29.50
24.88
16.16
5.57
1.94
Net Current Assets
173.63
149.60
117.60
92.53
65.78
36.02
27.88
Total Assets
1,363.78
872.85
670.14
538.60
371.00
252.30
196.86

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Mar 06
Mar 05
Cash From Operating Activity
117.54
92.11
68.12
47.77
17.76
31.73
38.38
PBT
58.28
49.07
37.75
34.46
27.06
23.35
20.83
Adjustment
94.53
73.99
53.75
37.63
28.14
22.05
17.33
Changes in Working Capital
-23.29
-22.58
-19.11
-20.43
-29.70
-8.24
5.56
Cash after chg. in Working capital
129.52
100.48
72.40
51.66
25.50
37.17
43.72
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-11.98
-8.37
-4.28
-3.89
-7.74
-5.43
-5.34
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-514.40
-220.15
-143.19
-163.21
-104.69
-56.73
-47.23
Net Fixed Assets
-128.48
-142.75
-104.93
-125.61
-83.26
-25.06
Net Investments
-325.20
-29.96
-21.69
-40.61
-30.81
-22.31
Others
-60.72
-47.44
-16.57
3.01
9.38
-9.36
Cash from Financing Activity
394.71
132.92
74.26
115.35
87.99
25.45
3.06
Net Cash Inflow / Outflow
-2.15
4.87
-0.81
-0.09
1.06
0.45
-5.79
Opening Cash & Equivalents
6.44
1.57
2.39
2.48
1.42
0.97
6.77
Closing Cash & Equivalent
4.29
6.44
1.57
2.39
2.48
1.42
0.97

Financial Ratios

Standalone /

Consolidated
Description
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Mar 06
Mar 05
Mar 04
Book Value (Rs.)
112.56
165.06
152.75
133.17
90.39
61.53
58.07
26.21
ROA
4.59%
5.51%
5.47%
6.53%
6.50%
8.19%
7.73%
10.34%
ROE
10.00%
15.52%
13.54%
17.96%
28.20%
34.69%
23.47%
23.83%
ROCE
8.77%
11.14%
11.12%
12.72%
15.18%
19.89%
18.77%
19.00%
Fixed Asset Turnover
0.51
0.47
0.47
0.59
0.71
0.71
0.76
0.88
Receivable days
77.35
84.81
91.82
81.14
74.35
66.79
50.16
58.80
Inventory Days
80.61
98.92
109.48
103.48
95.91
95.70
94.65
90.90
Payable days
15.54
20.32
18.46
15.92
19.15
22.70
12.86
3.41
Cash Conversion Cycle
142.42
163.42
182.84
168.70
151.11
139.79
131.95
146.30
Total Debt/Equity
0.63
1.42
1.22
0.83
2.01
2.10
1.63
0.95
Interest Cover
2.99
2.88
2.95
3.71
4.32
4.20
4.64
5.28

Annual Reports:

FY 2011
FY 2010

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.